U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116668) titled 'SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study' on Aug. 07.
Brief Summary: Colorectal cancer is the third most common malignancy worldwide and the second most common in the US. It is the second leading cause of cancer death worldwide, with 1.8 million new cases and 862,000 deaths per year. The majority of patients receive surgical treatment. Colorectal surgery is associated with a high risk of morbidity and mortality in comparison to other general surgery subspecialties. This study aims to further assess the safety and effectiveness of the Colovac Anastomosis Protection Device, a temporary intraluminal bypas...